Effect of wheat leaf ribonuclease on tumor cells and tissues
Jirí Skvor1, Petra Lipovová, Pavla Poucková
1Laboratory of Genetics, Department of Anthropology, Faculty of Science of the Charles University, Prague, Czech Republic.
Abstract:
The antiproliferative and antitumor effect of wheat leaf ribonuclease was tested in vitro on the human ML-2 cell line and in vivo on athymic nude mice bearing human melanoma tumors. The antiproliferative activity of this plant ribonuclease was negligible in comparison with bovine seminal ribonuclease. In the experiments in vivo, a significant decrease of the tumor size, however, was observed in the mice treated with wheat leaf ribonuclease (27 kDa) compared with the control RNase A and polyethylene glycol. In nude mice injected intratumoraly with wheat leaf ribonuclease, the tumor size decreased from 100% in the control mice to 39% in treated mice. In the mice treated with polyethylene glycol-conjugated wheat leaf ribonuclease, the tumor reduction was observed from 100 to 28%, whereas in counterparts treated with polyethylene glycol-conjugated bovine seminal ribonuclease the tumor inhibition was reduced from 100 to 33%. Certain aspermatogenic and embryotoxic activity of wheat leaf ribonuclease and bovine seminal ribonuclease also appeared, but was lower in comparison with the effect of onconase. Mutual immunological cross-reactivity between wheat leaf ribonuclease antigens on one side and animal RNases (bovine seminal ribonuclease, RNase A, human HP-RNase and onconase) on the other side proved a certain structural similarity between animal and plant ribonucleases. Immunogenicity of wheat leaf ribonuclease was weaker in comparison with bovine seminal ribonuclease (titer of antibodies 160-320 against 1280-2560 in bovine seminal ribonuclease). Interestingly, immunosuppressive effect of wheat leaf ribonuclease tested on mixed lymphocyte culture-stimulated human lymphocytes reached the same level as that of bovine seminal RNase. The antibodies against wheat leaf ribonuclease produced in the injected mice did not inactivate the biological effect of this plant RNase in vivo. This is probably the first paper in which plant ribonuclease was used as antiproliferative and antitumor drug against animal and human normal and tumor cells and tissues in comparison with animal ribonucleases.
Insights
Wheat leaf ribonuclease shows antitumor effects in vivo, reducing tumor size in mice. Despite lower antiproliferative activity in vitro, this plant-derived enzyme demonstrates potential as an antitumor drug.
Area of Science:
- Biochemistry
- Oncology
- Pharmacology
Background:
- Ribonucleases (RNases) are enzymes with potential therapeutic applications.
- Plant-derived RNases have been explored for their biological activities.
- Understanding the antitumor potential of wheat leaf ribonuclease (WLR) compared to animal RNases is crucial.
Purpose of the Study:
- To evaluate the antiproliferative and antitumor effects of WLR.
- To compare the efficacy of WLR with bovine seminal ribonuclease (BSR) and other RNases.
- To investigate the immunogenicity and immunosuppressive effects of WLR.
Main Methods:
- In vitro antiproliferative assays using human ML-2 cell line.
- In vivo antitumor studies in athymic nude mice bearing human melanoma tumors.
- Immunological cross-reactivity tests and antibody inactivation assays.
Main Results:
- WLR exhibited negligible antiproliferative activity in vitro compared to BSR.
- Significant tumor size reduction was observed in mice treated with WLR (39%) and PEG-conjugated WLR (28%) in vivo.
- WLR demonstrated structural similarity to animal RNases, weaker immunogenicity than BSR, and comparable immunosuppressive effects.
Conclusions:
- Wheat leaf ribonuclease possesses significant in vivo antitumor activity.
- WLR shows promise as a potential antitumor agent, warranting further investigation.
- This study is the first to compare plant ribonuclease's antitumor effects against animal RNases in vivo.
Related Concept Videos
The Nucleolus
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
